A Phase I/II Trial of Ruxolitinib with Chemotherapy for Patients with Relapsed and/or Refractory Philadelphia-like Acute Lymphoblastic Leukemia
Hannah Goulart, Elias Jabbour, Nicholas J. Short, Tapan M. Kadia, Naveen Pemmaraju, Koichi Takahashi, Farhad Ravandi, Marina Konopleva, Nitin Jain
Topics & Concepts
MedicineDasatinibRuxolitinibInternal medicineCohortOncologyChemotherapyRefractory (planetary science)GastroenterologyImatinibBone marrowMyelofibrosisAstrobiologyPhysicsMyeloid leukemiaAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsMyeloproliferative Neoplasms: Diagnosis and Treatment